PMC:7696151 / 43758-43935 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1217","span":{"begin":13,"end":17},"obj":"Species"},{"id":"1228","span":{"begin":32,"end":41},"obj":"Disease"}],"attributes":[{"id":"A1217","pred":"tao:has_database_id","subj":"1217","obj":"Tax:10116"},{"id":"A1228","pred":"tao:has_database_id","subj":"1228","obj":"MESH:D001168"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"se cells, in rats with adjuvant arthritis. At doses of 40 mg/kg daily, per oral administration (p.o.), it strongly decreased the blood concentration of neutrophil-derived oxidan"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T67","span":{"begin":32,"end":41},"obj":"Phenotype"}],"attributes":[{"id":"A67","pred":"hp_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/HP_0001369"}],"text":"se cells, in rats with adjuvant arthritis. At doses of 40 mg/kg daily, per oral administration (p.o.), it strongly decreased the blood concentration of neutrophil-derived oxidan"}